Actionable news
0
All posts from Actionable news
Actionable news in CARA: CARA THERAPEUTICS Inc,

Cara Therapeutics’ Data to be Presented at the British Association for Psychopharmacology 2016 Summer Meeting

STAMFORD, Conn., July 13, 2016 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that its preclinical data will be presented in a poster session at the British Association for Psychopharmacology (BAP) 2016 Summer Meeting, to be held in Brighton, UK from July 17 – 22, 2016.

Professor David J. Heal, Ph.D., D.Sc., F.R.C.S., Executive Director at RenaSci, Ltd., will present preclinical data on aspects of CR845's potential for abuse. The findings to be presented support the view that CR845 is unlikely to be recreationally abused or liable to cause physical dependence.

Details of the poster presentation are as follows:

Title: “Investigation of the discriminative...


More